BIIB059, a Humanized Monoclonal Antibody Targeting BDCA2 on Plasmacytoid Dendritic Cells (PDC), Shows Dose-Related Efficacy in the Phase 2 Lilac Study in Patients (PTS) with Active Cutaneous Lupus Erythematosus (CLE)

Rezultati

Naziv:	BIIB059, a Humanized Monoclonal Antibody Targeting BDCA2 on Plasmacytoid Dendritic Cells (PDC), Shows Dose-Related Efficacy in the Phase 2 Lilac Study in Patients (PTS) with Active Cutaneous Lupus Erythematosus (CLE)
Autori :	Werth, Victoria P.; ...; Radunović, Goran L ; ...; (broj koautora 17)
Godina:	2020
Publikacija:	Annals of the rheumatic diseases (Annual European Congress of Rheumatology (EULAR), Jun 03 2020)
ISSN:	0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Izdavač:	London : BMJ
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 79 br. Suppl 1 str. 120-121
DOI:	10.1136/annrheumdis-2020-eular.5743
WoS-ID:	000555905000192
URI:	https://enauka.gov.rs/handle/123456789/797164
URL:	https://ard.bmj.com/content/79/Suppl_1/120
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

1
OpenCitations

16
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.